David Ternant

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 16

Top Topics

Interstitial Lung Disease

Hodgkin Lymphoma

Monoclonal Antibody

Postmenopausal Women

Top Venues

Clinical pharmacokinetics

British journal of clinical pharmacology

Fundamental & clinical pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Yan-Min Xu, David Ternant, Martine Reynaud-Gaubert, Théodora Bejan-Angoulvant, Sylvain Marchand-Adam
Population pharmacokinetics of mycophenolate in patients treated for interstitial lung disease (EVER-ILD study). Fundamental & clinical pharmacology (2024)
Sarah Lobet, Morgane Caulet, Gilles Paintaud, Nicolas Azzopardi, Céline Desvignes, Romain Chautard, Christophe Borg, Olivier Capitain, Aurélie Ferru, Olivier Bouché, Thierry Lecomte, David Ternant
Confounding mitigation for the exposure-response relationship of bevacizumab in colorectal cancer patients. British journal of clinical pharmacology (2023)
Sarah Lobet, Gilles Paintaud, Nicolas Azzopardi, Christophe Passot, Morgane Caulet, Romain Chautard, Céline Desvignes, Olivier Capitain, David Tougeron, Thierry Lecomte, David Ternant
Relationship Between Cetuximab Target-Mediated Pharmacokinetics and Progression-Free Survival in Metastatic Colorectal Cancer Patients. Clinical pharmacokinetics (2023)
Blaise Pasquiers, Salih Benamara, Mathieu Felices, David Ternant, Xavier Declèves, Alicja Puszkiel
Translation of Monoclonal Antibodies Pharmacokinetics from Animal to Human Using Physiologically Based Modeling in Open Systems Pharmacology (OSP) Suite: A Retrospective Analysis of Bevacizumab. Pharmaceutics 15 (8) (2023)
Olivier Le Tilly, Philippe Gatault, Christophe Baron, Theodora Bejan-Angoulvant, Matthias Büchler, Gilles Paintaud, David Ternant
Is CD25 blockade optimal in kidney transplant patients treated with basiliximab? A target-mediated drug disposition model. British journal of clinical pharmacology 88 (7) (2022)
Nicolas Azzopardi, Hélène Longuet, David Ternant, Gilles Thibault, Valérie Gouilleux-Gruart, Yvon Lebranchu, Matthias Büchler, Philippe Gatault, Gilles Paintaud
Relationship Between Antithymocyte Globulin Concentrations and Lymphocyte Sub-Populations in Kidney Transplant Patients. Clinical pharmacokinetics (2021)
David Ternant, Olivier Le Tilly, Laurence Picon, Driffa Moussata, Christophe Passot, Theodora Bejan-Angoulvant, Céline Desvignes, Denis Mulleman, Philippe Goupille, Gilles Paintaud
Infliximab Efficacy May Be Linked to Full TNF-α Blockade in Peripheral Compartment-A Double Central-Peripheral Target-Mediated Drug Disposition (TMDD) Model. Pharmaceutics 13 (11) (2021)
Amina Bensalem, Denis Mulleman, Gilles Paintaud, Nicolas Azzopardi, Valérie Gouilleux-Gruart, Divi Cornec, Ulrich Specks, David Ternant
Non-Linear Rituximab Pharmacokinetics and Complex Relationship between Rituximab Concentrations and Anti-Neutrophil Cytoplasmic Antibodies (ANCA) in ANCA-Associated Vasculitis: The RAVE Trial Revisited. Clinical pharmacokinetics 59 (4) (2021)
Amina Bensalem, Guillaume Cartron, Ulrich Specks, Denis Mulleman, Emmanuel Gyan, Divi Cornec, Celine Desvignes, Olivier Casasnovas, Thierry Lamy, Stéphane Leprêtre, Gilles Paintaud, David Ternant
The Influence of Underlying Disease on Rituximab Pharmacokinetics May be Explained by Target-Mediated Drug Disposition. Clinical pharmacokinetics (2021)
David Ternant, Marc Pfister, Olivier Le Tilly, Denis Mulleman, Laurence Picon, Stéphanie Willot, Christophe Passot, Theodora Bejan-Angoulvant, Thierry Lecomte, Gilles Paintaud, Gilbert Koch
Infliximab Treatment Does Not Lead to Full TNF-α Inhibition: A Target-Mediated Drug Disposition Model. Clinical pharmacokinetics (2021)
Amina Bensalem, David Ternant
Pharmacokinetic Variability of Therapeutic Antibodies in Humans: A Comprehensive Review of Population Pharmacokinetic Modeling Publications. Clinical pharmacokinetics 59 (7) (2021)
Céline Desvignes, David Ternant, Thierry Lecomte, Astrid Lièvre, Marc Ohresser, Romain Chautard, William Raoul, Gilles Paintaud
A robust enzyme-linked immunosorbent assay to measure serum ramucirumab concentrations. Bioanalysis 13 (7) (2021)
Meriame Bennani Rtel, David Ternant, Matthias Büchler, Mohammed El Hassouni, Youssef Khabbal, Sanae Achour, Tarik Sqalli
Food and lipid intake alters the pharmacokinetics of cyclosporine in kidney transplants. Fundamental & clinical pharmacology 35 (2) (2020)
Olivier Le Tilly, Theodora Bejan-Angoulvant, Gilles Paintaud, David Ternant
Letter to Dreesen et al. on their article "Modelling of the Relationship Between Infliximab Exposure, Faecal Calprotectin, and Endoscopic Remission in Patients With Crohn's Disease"-A comprehensive review of infliximab population pharmacokinetic modelling publications. British journal of clinical pharmacology 87 (3) (2020)
David Ternant, Hélène Monjanel, Yann Venel, Caroline Prunier-Aesch, Flavie Arbion, Philippe Colombat, Gilles Paintaud, Emmanuel Gyan
Nonlinear pharmacokinetics of rituximab in non-Hodgkin lymphomas: A pilot study. British journal of clinical pharmacology 85 (9) (2019)
Amina Bensalem, Denis Mulleman, Gilles Thibault, Nicolas Azzopardi, Philippe Goupille, Gilles Paintaud, David Ternant
CD4+ count-dependent concentration-effect relationship of rituximab in rheumatoid arthritis. British journal of clinical pharmacology 85 (12) (2019)